about
Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan.Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics.A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.Nef, the shuttling molecular adaptor of HIV, influences the cytokine network.Emerging Viral Infections in Pakistan: Issues, Concerns, and Future Prospects.Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan.Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions.A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan.Sageretia thea (Osbeck.) mediated synthesis of zinc oxide nanoparticles and its biological applications.Sageretia thea (Osbeck.) modulated biosynthesis of NiO nanoparticles and their in vitro pharmacognostic, antioxidant and cytotoxic potential.Plant-based metallic nanoparticles as potential theranostics agents: bioinspired tool for imaging and treatmentPigments from Soil Bacteria and Their Therapeutic Properties: A Mini ReviewEndophyte-mediated synthesis of silver nanoparticles and their biological applicationsCurcumin-loaded self-emulsifying drug delivery system (cu-SEDDS): a promising approach for the control of primary pathogen and secondary bacterial infections in cutaneous leishmaniasisAnticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects
P50
Q35040102-32D68589-A645-4589-B7C1-D2C541CC9928Q35153914-E5DDC190-132A-4B83-837B-FB88FA3E6F18Q36181235-4A235554-C0B8-425B-956D-FB9AEC767228Q37608313-089D88A1-DA19-4BD5-B2DE-81F73CCB8528Q38295949-417DABF3-9855-46EF-AEE5-B4999120EB2DQ38668499-7215DCD2-BDD3-4145-8F31-4A731ACB4FD7Q42236748-BCCE5195-DBBC-480C-8EF1-293606ACAE59Q46280777-5C857280-FD9E-4359-AB72-F563964102D5Q50077326-DC9FB58A-8A0C-4275-9B43-1600088E15D7Q50895407-395FAC64-6F4F-48BC-8A29-7176D7F61E41Q50902809-F052B32A-A332-45F1-92D8-2B10CC567A22Q57139690-DD9A7F6D-477E-455C-9EB4-2295D91F0D70Q91277681-8B98FD22-9A2D-4B6A-9B32-63ED632B832FQ91352282-43AD90D7-6154-4223-B870-F7F1A408537CQ91842758-07E81510-86AF-4D10-8E4E-2CEDD161F0C8Q92354319-9E54D866-AFC3-4B43-A4DD-21BEA4CC25EA
P50
description
researcher ORCID ID = 0000-0002-7835-0663
@en
name
Muhammad Ali
@ast
Muhammad Ali
@en
Muhammad Ali
@es
Muhammad Ali
@nl
type
label
Muhammad Ali
@ast
Muhammad Ali
@en
Muhammad Ali
@es
Muhammad Ali
@nl
prefLabel
Muhammad Ali
@ast
Muhammad Ali
@en
Muhammad Ali
@es
Muhammad Ali
@nl
P106
P31
P496
0000-0002-7835-0663